Business Context and Reporting Period
This Form 8-K Current Report, dated February 21, 2024, covers significant corporate governance changes at Pulmonx Corporation. The filing details the resignation of the outgoing Chief Executive Officer, the appointment of a new CEO, and the departure of a board member.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements and personnel changes.
Material Changes
- CEO Transition: Glendon E. French resigned as President and CEO, effective March 15, 2024. He will serve as a Senior Advisor until May 1, 2024, and remain on the Board of Directors.
- New CEO Appointment: Steven S. Williamson was appointed President and CEO, effective March 15, 2024. He also joined the Board of Directors as a Class II member.
- Board Composition: Director Alissa Hsu Lynch will not stand for re-election at the 2024 annual meeting, reducing the board size to eight directors.
Compensation, Outlook, and Risks
New CEO Compensation Package
Steven S. Williamson's offer letter includes the following terms:
- Base Salary: $580,000 annually.
- Target Bonus: 75% of annual base salary.
- Equity Grants: A non-statutory stock option valued at $2,500,000 and a Restricted Stock Unit (RSU) award valued at $2,500,000 (calculated based on the trailing 60-day average closing price). Both vest over four years.
- Expenses: Reimbursement for travel and housing-related expenses.
Severance and Change in Control Provisions
Mr. Williamson is eligible for the Company's severance plan with the following triggers:
- Change in Control Period: If terminated without cause or resigns for good reason within 12 months of a change in control, he receives 18 months of base salary, 100% of the target bonus, 18 months of COBRA coverage, and 100% accelerated vesting of unvested equity.
- Outside Change in Control Period: If terminated without cause or resigns for good reason outside the change in control window, he receives 12 months of base salary and 12 months of COBRA coverage.
Outlook and Risks
The filing does not provide specific business guidance or outlook. The primary risk disclosed relates to the transition of leadership and the associated compensation obligations. The resignation of Director Alissa Hsu Lynch was explicitly stated as not related to any disagreement regarding operations, policies, or practices.
Investor Verification Checklist
- Verify the exact vesting schedule and performance conditions for Mr. Williamson's $5 million in initial equity grants.
- Review the full text of the Letter Agreement (Exhibit 10.1) regarding Mr. French's transition and continued board service.
- Confirm the impact of the board size reduction on committee compositions and quorum requirements.
- Assess the financial impact of the new CEO's compensation package relative to the company's current cash position and burn rate.